摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-azaniumyl-2-[(3-azaniumyl-3-carboxylatopropanoyl)amino]hexanoate

中文名称
——
中文别名
——
英文名称
6-azaniumyl-2-[(3-azaniumyl-3-carboxylatopropanoyl)amino]hexanoate
英文别名
——
6-azaniumyl-2-[(3-azaniumyl-3-carboxylatopropanoyl)amino]hexanoate化学式
CAS
——
化学式
C10H19N3O5
mdl
——
分子量
261.28
InChiKey
QGNYWQOMJSTUQZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5.3
  • 重原子数:
    18
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    165
  • 氢给体数:
    3
  • 氢受体数:
    5

文献信息

  • MICROFLUIDIC PROTEIN CRYSTALLOGRAPHY
    申请人:Hansen Carl L.
    公开号:US20110306522A1
    公开(公告)日:2011-12-15
    The use of microfluidic structures enables high throughput screening of protein crystallization. In one embodiment, an integrated combinatoric mixing chip allows for precise metering of reagents to rapidly create a large number of potential crystallization conditions, with possible crystal formations observed on chip. In an alternative embodiment, the microfluidic structures may be utilized to explore phase space conditions of a particular protein crystallizing agent combination, thereby identifying promising conditions and allowing for subsequent focused attempts to obtain crystal growth.
    微流控结构的使用使得蛋白质结晶的高通量筛选成为可能。在一种实施方式中,集成的组合混合芯片允许精确计量试剂,以快速创建大量可能的结晶条件,并在芯片上观察到可能的晶体形成。在另一种实施方式中,微流控结构可以用于探索特定蛋白质结晶剂组合的相空间条件,从而确定有前途的条件,并允许随后集中尝试获得晶体生长。
  • HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS
    申请人:California Institute of Technology
    公开号:US20140041727A1
    公开(公告)日:2014-02-13
    High throughput screening of crystallization of a target material is accomplished by simultaneously introducing a solution of the target material into a plurality of chambers of a microfabricated fluidic device. The microfabricated fluidic device is then manipulated to vary the solution condition in the chambers, thereby simultaneously providing a large number of crystallization environments. Control over changed solution conditions may result from a variety of techniques, including but not limited to metering volumes of crystallizing agent into the chamber by volume exclusion, by entrapment of volumes of crystallizing agent determined by the dimensions of the microfabricated structure, or by cross-channel injection of sample and crystallizing agent into an array of junctions defined by intersecting orthogonal flow channels.
    通过将目标材料的溶液同时引入微型流体装置的多个腔室中,实现对目标材料结晶的高通量筛选。然后,操纵微型流体装置来改变腔室中的溶液条件,从而同时提供大量的结晶环境。改变溶液条件的控制可以采用各种技术,包括但不限于通过体积排斥将结晶剂体积计量到腔室中,通过微型加工结构的尺寸确定结晶剂体积的困扰,或通过交叉正交流道定义的连接点阵列中的样品和结晶剂的交叉通道注入。
  • High throughput screening of crystallization materials
    申请人:California Institute of Technology, A California Corporation
    公开号:US20030061687A1
    公开(公告)日:2003-04-03
    High throughput screening of crystallization of a target material is accomplished by simultaneously introducing a solution of the target material into a plurality of chambers of a microfabricated fluidic device. The microfabricated fluidic device is then manipulated to vary the solution condition in the chambers, thereby simultaneously providing a large number of crystallization environments. Control over changed solution conditions may result from a variety of techniques, including but not limited to metering volumes of crystallizing agent into the chamber by volume exclusion, by entrapment of volumes of crystallizing agent determined by the dimensions of the microfabricated structure, or by cross-channel injection of sample and crystallizing agent into an array of junctions defined by intersecting orthogonal flow channels.
    目标材料结晶的高通量筛选是通过将目标材料溶液同时引入微型流体设备的多个腔室来实现的。然后操纵微型流体设备来改变腔室中的溶液条件,从而同时提供大量的结晶环境。对变化的溶液条件的控制可采用多种技术,包括但不限于通过体积排阻将结晶剂计量到腔室中,根据微制造结构的尺寸决定结晶剂的体积,或将样品和结晶剂跨通道注入由相交的正交流道定义的结点阵列中。
  • Microfluidic protein crystallography
    申请人:California Institute of Technology
    公开号:US20040115731A1
    公开(公告)日:2004-06-17
    The use of microfluidic structures enables high throughput screening of protein crystallization. In one embodiment, an integrated combinatoric mixing chip allows for precise metering of reagents to rapidly create a large number of potential crystallization conditions, with possible crystal formations observed on chip. In an alternative embodiment, the microfluidic structures may be utilized to explore phase space conditions of a particular protein crystallizing agent combination, thereby identifying promising conditions and allowing for subsequent focused attempts to obtain crystal growth.
    使用微流体结构可实现蛋白质结晶的高通量筛选。在一个实施方案中,集成组合混合芯片可精确计量试剂,快速创造大量潜在的结晶条件,并在芯片上观察可能的晶体形成。在另一个实施方案中,微流体结构可用于探索特定蛋白质结晶剂组合的相空间条件,从而确定有希望的条件,并允许随后进行重点尝试,以获得晶体生长。
  • Crystal growth devices and systems, and methods for using same
    申请人:Nassef Ramez Hany
    公开号:US20050019794A1
    公开(公告)日:2005-01-27
    High throughput screening of crystallization of a target material is accomplished by simultaneously introducing a solution of the target material into a plurality of chambers of a microfabricated fluidic device. The microfabricated fluidic device is then manipulated to vary the solution condition in the chambers, thereby simultaneously providing a large number of crystallization environments. Control over changed solution conditions may result from a variety of techniques, including but not limited to metering volumes of crystallizing agent into the chamber by volume exclusion, by entrapment of volumes of crystallizing agent determined by the dimensions of the microfabricated structure, or by cross-channel injection of sample and crystallizing agent into an array of junctions defined by intersecting orthogonal flow channels.
    目标材料结晶的高通量筛选是通过将目标材料溶液同时引入微型流体设备的多个腔室来实现的。然后操纵微型流体设备来改变腔室中的溶液条件,从而同时提供大量的结晶环境。对变化的溶液条件的控制可采用多种技术,包括但不限于通过体积排阻将结晶剂计量到腔室中,根据微制造结构的尺寸决定结晶剂的体积,或将样品和结晶剂跨通道注入由相交的正交流道定义的结点阵列中。
查看更多

同类化合物

(-)-N-[(2S,3R)-3-氨基-2-羟基-4-苯基丁酰基]-L-亮氨酸甲酯 鹅肌肽硝酸盐 非诺贝特杂质C 霜霉灭 阿洛西克 阿沙克肽 阿拉泊韦 门冬氨酸缩合物 铬酸酯(1-),二[3-[(4,5-二氢-3-甲基-5-羰基-1-苯基-1H-吡唑-4-基)偶氮]-4-羟基-N-苯基苯磺酰氨酸根(2-)]-,钠 铝(1E)-2-[6-[[氨基-[[氨基-[(4-氯苯基)氨基]亚甲基]氨基]亚甲基]氨基]己基]-1-[氨基-[(4-氯苯基)氨基]亚甲基]胍2-羟基丙酸酯(2R,3S,4R,5R)-2,3,4,5,6-五羟基己酸N-四醛英-5-基-4,5-二氢-1H-i 钠(6S,7S)-3-(乙酰氧基甲基)-8-氧代-7-[(1H-四唑-1-基乙酰基)氨基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯 金刚西林 醋酸胃酶抑素 酪蛋白 酪氨酰-脯氨酰-N-甲基苯丙氨酰-脯氨酰胺 酒石酸依格列汀 透肽菌素A 连氮丝菌素 远霉素 达福普丁甲磺酸复合物 达帕托霉素 辛基[(3S,6S,9S,12S,15S,21S,24S,27R,33aS)-12,15-二[(2S)-丁烷-2-基]-24-(4-甲氧苄基)-2,8,11,14,20,27-六甲基-1,4,7,10,13,16,19,22,25,28-十羰基-3,6,21-三(丙烷-2-基)三十二氢吡啶并[1,2-d][1,4,7,10,13,16,19,22,25,28]氧杂九氮杂环三十碳十五烯并 谷胱甘肽磺酸酯 谷氨酰-天冬氨酸 表面活性肽 表抑氨肽酶肽盐酸盐 葫芦脲 水合物 葫芦[7]脲 葚孢霉酯I 荧光减除剂(OBA) 苯甲基3-氨基-3-脱氧-α-D-吡喃甘露糖苷盐酸 苯唑西林钠单水合物 苯乙胺,b-氟-a,b-二苯基- 苯乙胺,4-硝基-,共轭单酸(9CI) 苯丙氨酰-甘氨酰-缬氨酰-苄氧喹甲酯-丙氨酰-苯基丙氨酸甲酯 苯丙氨酰-甘氨酰-组氨酰-苄氧喹甲酯-丙氨酰-苯基丙氨酸甲酯 苯丙氨酰-beta-丙氨酸 苯丁抑制素盐酸盐 苦参碱3 苄氧羰基-甘氨酰-肌氨酸 芴甲氧羰基-4-叔丁酯-L-天冬氨酸-(2-羟基-4-甲氧基)苄基-甘氨酸 艾默德斯 腐草霉素 脲-甲醛氨酸酯(1:1:1) 胃酶抑素 A 肠螯素铁 肌肽盐酸盐 肌氨酰-肌氨酸 肉桂霉素 聚普瑞锌杂质7